Needham & Company LLC Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $50.00
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target cut by stock analysts at Needham & Company LLC from $52.00 to $50.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price points to a potential upside […]
